ෞࢸणۛ৪͈᫭មထཡ̤̫ͥͅఉثະ཈გডཛॸוူൎဓ͈࠿൦ Effect of Enteral Nutrition

ਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭࢌ‫ڠ‬໐ȁਜ਼ഛ൴༗࠲ۭࢌࡄ‫ݪ‬ȁలˏ‫ے‬ȪijıIJĶȫ
15
ࡄ‫ݪ‬༭࣬
ਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭࢌ‫ڠ‬໐ȁਜ਼ഛ൴༗࠲ۭࢌࡄ‫ ݪ‬Ĵ
P.15 - 20ġĩ2015ȫ
ෞࢸणۛ৪͈᫭មထཡ̤̫ͥͅఉ‫ث‬ະ཈გডཛॸ‫ူו‬ൎဓ͈࠿൦
Effect of Enteral Nutrition with Eiconosapentaenoic Acids for Preventing
Pressure Ulcers in Patients with Cerebral Infarction.
ࣱȁ୼ȁ‫ج‬ȁঊˍȫȁ઀ȁ୼ȁȁȁ߰ IJĭijĪȁ߬ȁఆȁ੓ȁঊˍȫ
KUROKAWA Yoshiko
OGAWA Kaoru
ˏȫ
KUWAMURA Junko
५ȁུȁఽȁঃ ȁඃȁ୼ȁઽȁহ ȁġ଩ȁఆȁȁȁࢨːȫ
TAMAMOTO Takuji
ˏȫ
TOKUGAWA Joji
SUGIMURA Sachi
ါȁক
࿒എȇఉ‫ث‬ະ཈გডཛॸ̜́ͥ΀ͼ΋΍βϋΗ΀ϋॸȪո‫ ئ‬EPA ͂ၞ̳ͥȫ͈ൎဓͥ͢ͅ᫭ម
อ୆͈ထཡ࢘‫࠿ͬض‬൦̳̹ͥ͛Ȃ᫭មอ୆͈ΧͼςΑ·͂ࣉ̢ͣͦͥփেવ‫৽ͬٺ‬ஶͅ‫ݢݣ‬เ
௣̯ͦව̱̹֭ෞࢸणۛ৪ͅచ̱̀Ȃ̷͈࢘‫࠿͈ض‬൦࣐̹ͬ̽ȃ
చય༹̤͍༷͢ȇGlasgow Coma Scale12 തո‫́ئ‬ව֭ࢃː඾ոષ͈հ୓ͬထ೰̱̞̀ͥෞࢸ
णۛ৪ː႕ͬచય̱̹͂ȃව֭ೄࢃ̥ͣ EPA ൎဓ߲ˎ႕͂Ȃచચ߲̱͂̀ EPA ๱ൎဓ߲Ȫ΋
ϋΠυȜσ߲ȫˎ႕̫ͩͅȂIJĵ ඾‫ۼ‬κΣΗςϋΈ̱Ȃ૧͈ܰ᫭មอ୆ອഽ͞‫ڎ‬ਅΩριȜῌ
̞̾̀๤‫࠿ڛ‬൦̱̹ȃ
଼ୡȇEPA ൎဓ߲͉Ȃ΋ϋΠυȜσ߲ͅ๤͓̀᫭ម͈อ୆̦෇̥̹͛ͣͦ̈́̽ȃ̹͘ȂEPA ൎ
ဓ߲͉ςϋΩ‫͈ݩ‬౵̦ࣞ౵ͬা̱Ȃ྾‫ܥע‬ෝ̦̥̹ࣞ̽ȃ
ࠫაȇ᫭មอ୆͈ΧͼςΑ·͂ࣉ̢ͣͦͥಎ൝છȡਹછփেવ‫̜͈ͥٺ‬ෞࢸणۛ৪͈છ႕ͅచ
̱̀ EPA ͈ൎဓ࣐̠̭͉ͬ͂Ȃ‫׶‬છ฽؊ͬဲଷ̱Ȃ᫭មอ୆͈ထཡ࣓ͅࡃ̳ͥ‫خ‬ෝ଻̞̾̀ͅ
াऐ̧̹́ȃ
ȁȁ॑ ֨ ဥ ࢊȇ᫭មȂထཡȂ΀ͼ΋΍βϋΗ΀ϋॸȂ‫ူו‬
ȁȁKey wordsȇpressure ulcer, prevention, eicosapentaenoic acid, nutrition
ԅȅ੨ȁ࡞
̤ͤȂ̷͈̠̻͈ါٚࢌ৪൝̞̾̀ͅȂٚࢌ̦ຈါ
ȁٚࢌ༗ࡏଷഽ̤̫ͥͅါٚࢌ৪ྌ͉ါ঑‫׳‬৪͂෇
̹̈́̽ͅ৽̈́ࡔ֦̞͙̾̀ͥ͂ͅȂ
ȶෞࠬ‫ۯ‬৖ۛȷ̦
೰̯̹ͦ૽͉Ȃ໹଼ ijij ාഽྎ́ Ķıķįij ྔ૽͂̈́̽̀
ijIJįĶɓ͂ड͜ఉ̞ˍȫȃෞࠬ‫ۯ‬৖ۛۛ৪͉඾ུ஠࣭ͅ
ijĸij ྔ૽ంह̱Ȃ̷͈̠̻ IJķı ྔ૽̦ါٚࢌેఠ́
ˍȫਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭࢌ‫ڠ‬໐
ˎȫਜ਼ഛ൴ఱ‫ڠ֓ڠ‬໐ક‫ܕا‬ඤ‫ش‬
ˏȫਜ਼ഛ൴ఱ‫ڠ֓ڠ‬໐້௺୓‫ؖ‬ພ֭ෞ૰ࠐ‫شٸ‬
ːȫਜ਼ഛ൴ఱ‫ڠ֓ڠ‬໐້௺୓‫ؖ‬ພ֭
ˍȫJuntendo University Faculty of Health Sciences and Nursing
ˎȫJuntendo University School of Medicine, Department of Gastroente
rology
ˏȫJuntendo University Shizuoka Hospital, Department of Neurosur gery
ːȫJuntendo University Shizuoka Hospital
ȁȁĩNovį 14ĭ 2014 ࡔࣂ਋ັȫ
ȪJanį 16, 2015 ࡔࣂ਋ႀȫ
̜̞̠ͥ͂༭̜࣬ͥ͜ȃ̹͘Ȃါٚࢌ৪൝̥͙̹ͣ
৽̈́ٚࢌ৪͈௽໻͉Ȃ˒‫ڬ‬ոષ̦൳‫̦૽̞̱ͥ̀ݳ‬
ٚࢌ৪̤͂̈́̽̀ͤȂ̷͈ٚࢌ৪͈ාႢ͉Ȃ౳଻́
͉ ķĵįĹɓȂ੫଻͉́ ķıįĺɓ̦ ķı पոષ̜́ͤȂ̞
ͩͥ͠ȶჇșٚࢌȷ͈ΉȜΑ͜௖൚ତంह̱̞̀ͥˍȫȃ
̭ͦͣါٚࢌ৪͉ͅ᫭ម̦อ୆̱̳̞̭̦͂͞౶ͣ
QOL
̤ͦ̀ͤȂ᫭ម͉ါٚࢌ৪͈୆ྵထࢃȆ ͬಠ
16
ࣱ୼‫ج‬ঊȇෞࢸणۛ৪͈᫭មထཡ̤̫ͥͅఉ‫ث‬ະ཈გডཛॸ‫ူו‬ൎဓ͈࠿൦
̱̩೩‫̵̩̫̺̯̈́́ͥئ‬Ȃۭࢌٚ͞ࢌ͈਀‫ͬۼ‬௩
֓ၷ๯͈ॉࡘ൝Ȃఉ࿂എ̈́Ήͺ͈٨஝̤͍͢΋ΑΠ
̳̭͂͂̈́ͥ͞ȃࣽٝచય̱̹͂փেવ‫৽ͬٺ‬ஶͅ
ॉࡘ࣓ͅࡃ̧́ͥ͂ࣉ̢ͣͦͥȃ
‫ݢݣ‬เ௣̯ͦව̱̹֭ෞࢸणછ႕͉́Ȃව֭ಎ͈αΛ
ȁུࡄ‫͉́ݪ‬Ȃಎ൝છȡਹછփেવ‫৽ͬٺ‬ஶͅ‫ݢݣ‬
Ρષհ୓͞ఘպ࢐۟ࣾඳͤ͢ͅȂ̯ͣͅ᫭មอ୆͈
เ௣̯ͦව̱̹֭ෞࢸणછ႕͈᫭មอ୆ອഽͬ಺औ
ςΑ·̦̩ࣞ̈́ͥȃ̷͈̹͛ȂίυΠ΋Ȝσͅ੔‫ݶ‬
̱Ȃอ୆̱̹ۛ৪̷̤̞͉͈̀ͅඅಭͬྶ̥̱ͣͅ
̱ۭ̀ࢌΉͺ̤̭̞ͬ̈́̽̀̀͜อ୆̳ͥ᫭ម̾ͅ
̹ȃ̹͘Ȃņőł ͈ൎဓ̦᫭មอ୆͈ဲଷ̦̾̈́ͥͅ
̞͉̀Ȃਲြ͈Ήͺ͈஖఼ঠո‫͈̥ͣٸ‬ါ֦ͬ࿅॑
͈̥Ȃ̷͈࢘‫࠿ͬض‬બ̱̹ȃ
̳ͥຈါ̦̜ͥȃ᫭ម͉̹͍͌͂อ୆̳ͥ͞Ȃۛ৪
ུ૽͈ߎ೑̺̫̩ۭ́̈́ࢌਲম৪ٚ͞ࢌ̤̭̠ͬ̈́
Ԇȅచય༹͍༷̈́ͣͅ
‫ز‬௼͜ͅఱ̧̈́໅౜͂̈́ͥȃ̭ͦ́͘᫭មထཡ̾ͅ
ˍȅచય
̞͉̀Ȃ‫ူו‬ၷ༹̱͂̀ΗϋΩ·ৗȂΫΗηϋȂη
ȁո‫͈ئ‬ഴ჏‫ܖ‬੔ͅ‫̞̀̿ܖ‬ȂS ࡇඤ͈‫ܢ଻ݢ‬ພ֭ͅ
Υρσ႒͈༞‫ͬݯ‬ଔ੻̳͈̦͕̜̹ͥ͂ͭ̓́̽͜ȃ ව֭ಎ͈ۛ৪ͬచય̱͂஖೰̱̹ȃ
᫭មͅ‫̳ͥ۾‬ٚවࡄ‫͉́ݪ‬Ȃࠐ࢛എͅ໦‫ॸܚ‬ͺηΦ
Ȫഴ჏‫ܖ‬੔ȫ
ॸͬ೏‫̭̹̱́͂ح‬Ȃ᫭ម͈٨஝̦̹̞̾̈́̽͂ͅ
ġˍȫGlasgow Coma ScaleȪո‫ ئ‬GCS ͂ၞȫġIJij തո
̠છ႕༭̦̯̞࣬̈́ͦ̀ͥˎȫȃఉ‫ث‬ະ཈გডཛॸ͈᫭
ȁ‫͈ئ‬փেવ‫̜̦ͥٺ‬ෞࢸणછ႕
ម࢘‫͉̞̀̾ͅض‬Ȃ઀୼ͣˏȫͤ͢ͅಿ‫ٓަͅܢ‬պ́հ
ġˎȫව֭ࢃː඾ոષ͈հ୓ͬထ೰̱̞̀ͥછ႕
୓ેఠͬ༗̾ຈါ̦̜ͥۛ৪ͅచ̱̀Ȃ΀ͼ΋΍β
ġˏȫව֭ಎ͈ࠐ‫ࠐۯ‬ಸ‫̦ူו‬ഐ୨̈́છ႕
ϋΗ΀ϋॸȪEPAȫ
ȆϹ- ςΦτϋॸȪGLAȫ‫اޑ‬ෛ࢚
ġːȫ౳੫͂͜ͅ ijı पոષ̜̭́ͥ͂
ၠ൲૙ͬဥ̞̹‫ۯူו‬ၑ࣐̠̭͉ͬ͂᫭មထཡ͈ခ
ġˑȫ໲੥ུͥ͢ͅ૽̜̞͉ͥ‫ز‬௼൝͈൳փ̦ංͣͦ
ဥ̈́஖఼ঠ͂̈́ͤං̭̦ͥ͂ྶ̥̹ͣ͂̈́̽ȃఉ‫ث‬
ȁ̭ͥ͂
ະ཈გডཛॸ͉ࢯ‫׶‬છैဥ̱͂̀‫׶‬છ଻΀ͼ΋Φ΍
Ȫੰ‫ܖٸ‬੔ȫ
ͼΡ͈ॲ୆ͬဲଷ̳ͥैဥ̦̜ͥĵĪĭ ĶĪĭ ķĪȃ̱̥̱Ȃࠐ‫ۯ‬
ġˍȫළິ̹͉͘਎඿ິ
‫ٳူו‬ইশ͉Ȃક‫ܕا‬છે൝̦੄࡛̱̳̩͞Ȃ਱໦
ġˎȫාႢ ijı पྚྖ͈છ႕
̈́૙‫׎‬ൎဓ̦ࣾඳ́‫ેူו‬ఠ̦՛‫̳ͥا‬છ႕̦ఉ̞ȃ ġˏȫ୆ྵထࢃ̧̦ͩ͛̀ౣ̞Ȫဒྵ ijĹ ඾ྚྖȫ͂ထ
̷͈̹͛Ȃࠐ‫ူוۯ‬൵වশ̤̫ͥͅ‫ેူו‬ఠ͈೩‫ئ‬
ȁ௶̯ͦͥછ႕
ͬཡ̪̹͛ͅȂ༞੩‫ͥ͢ͅူו‬ͺίυȜΙ̦ຈါ͂
ġːȫࠬൠ‫ۯ‬ၑ̦ޭ͛̀ࣾඳ̈́ൠෂພછ႕ȪHbA1C Ʉ
̈́ͥȃ̷̭́ȂࣽٝȂࣞডࠬછ͈٨஝൝ͅႉ઄́ఉ
ȁIJıįıĦȫ
̩ঀဥ̯̞ͦ̀ͥఉ‫ث‬ະ཈გডཛॸ͈ͼ΋΍βϋΠ
ġˑȫͼτ;Α̜̞͉ͥಸ‫ܥ͈ۯ‬ෝ̦ॼం̱̞̞̀̈́
ॸ΀Ισͬঀဥ̱Ȃ࠿બ̤̭̹ͬ̈́̽ȃͼ΋΍βϋ
ȁࠐಸ‫̦ူו‬ະഐ؊͈છ႕
Πॸ΀Ισ͉Ȃਹఱ̈́໗ैဥ͈੄࡛ອഽ̦೩̞̭͂
ġ˒ȫਹഽ̈́྾‫ڠע‬എဲଷછ႕Ȫฒࠬ‫ݩ‬ତɃ IJıııcells
̦ྶ̥̤ͣ̈́̽̀ͤͅȂ̹͘Ȃ‫̦ڒث‬հ‫̭̜ͥ́ث‬
/mm ȫ
̥͈͂ͣࣽٝঀဥͅঢ̹̽ȃ̭ͦ́͘᫭ម͈ထཡͅ
ġ˓ȫࣞডࠬછ႕ȪTG Ʉ Ķıımg/dlȂT-Cho Ʉ Ĵıımg
̞̾̀࠿൦̦̯̭̥̹ͦ̀̈́̽ ņőł ͈ൎဓͤ͢ͅ᫭
/dlȫ
ម͈ထཡ࢘‫̦࢜ض‬ષ̳͈̜ͥ́ͦ͊Ȃۛ৪໅౜͂ͅ
ġ˔ȫ΋ϋΠυȜσະၻ͈‫ئ‬ၓછ႕
̴̓ͣ͘Ȃۭࢌ͍̈́ͣٚͅࢌ໅౜͈ࠚࡘȂ̯͉ͣͅ
ġ˕ȫঀဥၠ൲૙ͅ‫଼̞ͥ̀ͦ͘܄‬໦ͅͺτσΆȜ̦
3
ਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭࢌ‫ڠ‬໐ȁਜ਼ഛ൴༗࠲ۭࢌࡄ‫ݪ‬ȁలˏ‫ے‬ȪijıIJĶȫ
17
ȁ̜ͥછ႕
ͅ֊࣐̳ͥ͂হၷඤယ̦་ࢵ̳̹ͥ͛Ȃ᫭មࠁ଼ͅ
IJıȫΑΞυͼΡঀဥછ႕
‫̢ͦͣࣉ̜̦͂ͥޣג‬Ȃडಿ IJĵ ඾‫ͬۼܢ͂ۼ‬୭೰̱
IJIJȫུদࡑ͈ഴ჏ஜ Ĵı ඾ոඤͅఈ͈হࡑ൝ͅ४‫̱ح‬
̹ȃࠐ‫ࠐۯ‬ಸ‫͉ူו‬Ȃࠐ࢛૙̦‫ٳ‬ই͂̈́ͤࠐ‫ࠐۯ‬ಸ
ȁ̞̀ͥછ႕ȃ
‫΀͈̥ͣူו‬ΥσΆȜ୫৾ၾ̦ຈါ΀ΥσΆȜၾ஠
IJijȫ̷͈ఈȂ৽හࡄ‫ݪ‬৪൝ུ̦দࡑͬ৘ঔ̳̭ͥ͂
ఘ͈ ĸĶɓո‫̹̽̈́͂ئ‬শത́ਞၭ̱̹͂ȃ࿶‫̾ͅס‬
ȁͬະഐ൚͂฻౯̱̹છ႕ȃ
̞͉̀Ȃডཛ඿स͈ঀဥ͉޺‫̹̱͂ܝ‬ȃEPA ͈ൎဓ
༹༷͂ൎဓၾ͉Ȃͼ΋΍βϋΠॸ΀Ισ IJĹıımg ͬ
ˎȅ༹༷
ಱတˎٝͅ໦̫ࠐ‫ࠐۯ‬ಸ‫͈ူו‬षͅࠐ‫ۯ‬ൎဓ̱̹ȃ
ˍȫদࡑΟΎͼϋ
ˏȫ಺औࣜ࿒
ྫैև‫ັڬ‬ႉ઄দࡑ
ȁGCSIJij തո‫͈ئ‬ಎ൝છȡਹછփেવ‫̜͈ͥٺ‬ෞࢸ
णۛ৪́ව֭ࢃː඾ոષ͈հ୓ͬထ೰̱̞̀ͥછ႕
̞̾̀ͅȂව֭ೄࢃ̥͈ͣ ņőł ൎဓ߲͂Ȃచચ̱͂
Ȫˍȫ૸ఘࠗ௶ȇ૸ಿ ļ ව֭শȃఘਹ ļ ව֭শȆൎဓࢃ
ȁIJĵ ඾࿒
Ȫˎȫ᫭ម૷౯ȇDESIGN-R ͬဥ̞̀Ȃව֭ೄࢃ̥ͣ
ȁൎဓࢃ IJĵ ඾࿒ྀ́͘඾ȃ
̀ EPA ๱ൎဓ߲Ȫո‫ئ‬΋ϋΠυȜσ߲̳͂ͥȫͅ໦̫Ȃ Ȫˏȫࠬ‫࠿ס‬औȇࠬ‫࠿๊֚ס‬औ ļ ୤ࠬ‫ݩ‬ତ ĭ ฒࠬ‫ݩ‬ତ ĭ
᫭មอ୆ອഽ̞̾̀ͅ DESIGN-RȪ඾ུ᫭ម‫ڠ‬ٛġ ᫭
Hbĭġ Htĭ ฒࠬ‫ݩ‬໦ْ ĭ ࠬ઀โତ ļ ව֭শȆEPA ൎဓ
មેఠ฻೰ΑΉȜσȫͅ‫̧̿ܖ‬ບ‫̹̱ث‬ȃ‫ူו‬Ήͺ
ȁࢃˍĭ ːĭ ˓ĭIJĵ ඾࿒ȃࠬ‫ס‬୆‫࠿ڠا‬औ ļ ௙̹̩ͭ͋ ĭ
ո‫͈ٸ‬হၷ͍ۭ̈́ͣͅࢌΉͺ̞͉̾̀ͅȂۛ৪ࡢș
ȁͺσήηϋ ĭ ΠρϋΑέͿςϋ ĭ τΙΦȜσࣣ̹ࠫ
͈ેఠͅ‫̹̞֭̿ܖ‬ඤ͈ດ੔എ̈́ΉͺίυΠ΋Ȝσ
ȁ̩ͭ͋ ĭ ίτͺσήηϋ ĭġBUNĭġCRPĭġ௙΋τΑΞυ
ͅ੔‫̹̱̭̳͂͂ͥݶ‬ȃ
ȁȜσ ĭġ HDL ΋τΑΞυȜσ ĭġ LDL ΋τΑΞυȜσ ĭ
ȁΟȜΗਓਬ‫͉ۼܢ‬ȂijıIJĵ ාˍ࠮ȡˎ࠮̜̹́̽ȃ
ȁಎ଻ডཛ ĭ ডཛॸ໦ْ ĭ ࠬൠ ļ ව֭শȆEPA ൎဓࢃ
ˎȫൎဓ༹༷
ȁˍĭ ːĭ ˓ĭIJĵ ඾࿒ȃHbA1Cĭ ࠬୄͼϋΑςϋ ļġව֭শȆ
ȁව֭ೄࢃͅࠐ‫ࠐۯ‬ಸ‫ူו‬ൎဓȪĴıı ȡ ĵııKcalİ ٝȫ
ȁEPA ൎဓࢃ IJĵ ඾࿒ȃ
ͬ೩௸ഽ̥ͣ‫ٳ‬ই̱Ȃ࿒ດൎဓ΀ΥσΆȜ̱͂̀ດ੔
ːȫບ‫ࣜث‬࿒
ఘਹȪŬŨȫȿ ĴıKcalİ ඾ͬၠ൲૙́ൎဓ̧̠́ͥ͢
෇ယ଻ͬ‫̦̱ͣ̈́෇ږ‬ഐܽ௸ഽͬஞ௩̱̹ȃࠐಸ‫ူו‬
ΙνȜή͈୶౤͉֍ඤၣ౾̱̹͂ȃൎဓ༹༷͉ࡔ௱എ
Ȫˍȫ৽ါບ‫ࣜث‬࿒ȇ૧ܰͅอ୆̱̹᫭ម ĩDESIGN-R
́ບ‫̱ث‬ȂdIJ ոષ͈ତ̳͂ͥ Īİ ඾
Ȫˎȫ໗ষບ‫ࣜث‬࿒ȇခ‫ٺ‬মયȂႉ઄࠿औ౵։ુ
ͅ঵௽ൎဓ༹༷̳̦͂ͥȂક‫ܕا‬છે൝ͬ‫̱̈́෇ږ‬
ˑȫႃၑഎ෻ၪ
̦ͣ‫ۼ‬ᗰൎဓͅ୨ͤఢ̢̭ͥ͂͜‫خ‬ෝ̱̹͂ȃडౣ
ӱࡄ‫͈ݪ‬చય͂̈́ͥ৪͈ఄࡕ͂૽ࡀ͈သࢌͅ‫̳ͥ۾‬
ː඾‫ۼ‬୫̵̯৾Ȃडಿ IJĵ ඾‫ۼ‬κΣΗςϋΈ࣐̹ͬ̽ȃ ෻ၪ
ൎဓ‫͉̞̀̾ͅۼܢ‬ȂEPA ൎဓࢃࠬᚋಎෛഽ͉ൎဓ
ȁদࡑͅ୶ၛ̻Ȃਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭࢌ‫ڠ‬໐ࡄ‫ݪ‬ႃၑտ
඾ତͅਲ̞੭șͅષઌ̱Ȃൎဓˑȡ˒඾࿒ͅ೰ુેఠ
֥ٛȪઇ෇๔࣢ ijĶıIJıȫ̤͍͢ਜ਼ഛ൴ఱ‫ڠ֓ڠ‬໐້
ͅో̱̹̞̠͂ࠫ‫̭̜̦͂ͥض‬Ȃ̹͘Ȃෞࠬ‫ۯ‬৖͈ۛ
௺୓‫ؖ‬ພ֭ႃၑૣऔտ֥ٛȪ‫خݺ‬๔࣢ႃȽ Ĵijĸȫ͈
‫̫̤ͥͅܢ଻ݢ‬ঘཌၚ͉ˏ඾ոඤͅఉ̞̹͛Ȃडౣː
ઇ෇͈࢚͂͜୆Ⴛ൱જ͈ȶႉ઄ࡄ‫̳ͥ۾ͅݪ‬ႃၑঐ
Ȃ‫͍ݞ‬ȶΰσΏϋ΅୹࡞ȷͅ௱ͤ৘ঔ̱̹ȃ
඾‫ۼ‬୫̱̹৾͂ȃडಿ IJĵ ඾‫͈ۼ‬ൎဓ‫͉̞̀̾ͅۼܢ‬Ȃ ૻȷ
ෞࢸण͈‫͉ܢ଻ݢ‬อછˍȡˎ਩‫ۼ‬ոඤ̜́ͤȂྕ଻‫ܢ‬
Ӳࡄ‫͈ݪ‬చય͂̈́ͥ৪͈஖೰༹༷̤͍͢๭ࡑ৪ͅ୰
18
ࣱ୼‫ج‬ঊȇෞࢸणۛ৪͈᫭មထཡ̤̫ͥͅఉ‫ث‬ະ཈გডཛॸ‫ူו‬ൎဓ͈࠿൦
ྶ̱൳փͬං༹༷ͥ
ນˎ ᫭មอ୆
ȁచય͂̈́ͥ৪͈஖೰͉Ȃષܱഴ჏‫ܖ‬੔ͬྖ̹̳͈͜
̦ව̱̹֭षͅȂ౜൚֓঍ͤ͢ͅྫैևͅಒ੄࣐ͬ̽
̹ȃ‫༹͉̞༷͈̫̀̾ͅັڬ‬Ȃ໑ൟ༹ͬဥ̞̀৘ঔ
̱̹ȃ๭ࡑ৪͈͒୰ྶ̞͉̾̀ͅȂུ૽̹͉͘యౄ
৪ͅచ̱̀౜൚֓঍ͤ͢ࡄ‫͈ݪ‬ਇক༹༷͂Ȃࡄ‫ފݪ‬
ႁ͈හփ଻͂൳փ͈ക͈ٝࡀ၌൝̞̾̀ͅ໲੥́୰
ȁ᫭ម͈૧ܰอ୆̞̾̀ͅȂ΋ϋΠυȜσ߲͉́ව֭
ྶ̱Ȃࡄ‫ৃͬݪ‬ప̯ͦ̀ࣽ͜ࢃ͈হၷͅະ၌‫̈́ͅף‬
IJIJ ඾࿒́ˍພ་ֲীٚͅ᫭មȪ૯๧͈́͘అੱȫͬ
̞̭ͣ̈́͂ͬၑ̢ٜ̱̹̠́Ȃদࡑͅ४‫̭̳͂ͥح‬
෇̹͈͛ͅ๤͓Ȃņőł ൎဓ߲̤̞͉̀ͅȂ᫭ម͈อ
ུͅ૽̹͉͘యౄ৪̥ͣ໲੥ͥ͢ͅ൳փͬං̀দࡑ
୆͉෇̥̹͛ͣͦ̈́̽Ȫນˎȫ
ȃȁȁȁȁȁ
̤̭̹ͬ̈́̽ȃ
ȁ ͘ ̹ȂEPA ൎ ဓ ߲ ͉ ΋ ϋ Π υ Ȝ σ ߲ ͂ ๤‫̱̀ڛ‬
ӳঔ୭ͅၑٜͬ‫͛ݥ‬൳փͬං༹༷ͥ
˓඾࿒ո͉ࣛ ņőł ͈ࠬಎෛഽ̦ࣞ౵ͬা̱̤̀ͤȂ
ȁࡄ‫ݪ‬ঔ୭ͅచ̱̀ႉ઄ࡄ‫ݪ‬૭୏̤̭̞ͬ̈́Ȃ൳փ
EPA ͉ࠬಎ͒‫ږ‬৘ͅൎဓ̯̞̭̦ͦ̀ͥ͂෇͛ͣͦ
ͬං̀৘ঔ̱̹ȃ̹͘ȂࣽٝȂ಺औࣜ࿒ܱͬව̳ͥ
̹Ȫ଎ˍȫ
ȃ
ۭࢌ঍ͅచ̱̀Ȃࡄ‫͈ݪ‬ਇকͬ୰ྶ̱Ȃ‫ږ‬৘ͅ‫ފ‬ႁ
ȁষͅȂ‫׶‬છ฽؊͈ঐດ͂̈́ͥ CRPȪ଎ˎȫ͂྾‫ע‬
ͬං̥̀ͣࡄ‫̹̭̤̽̈́ͬݪ‬ȃ̹͘Ȃ᫭មอ୆শ͉ͅȂ
‫ވ‬൳ࡄ‫ݪ‬৪́๧ໂȆෳᘩ෇೰΢ȜΑ͈͒Ⴒ၁ͬഔೲ
̱Ȃഐ୨̈́฻೰̤̭̹ͬ̈́̽ȃΉͺ͈৘ঔ̞͉̾̀ͅȂ
ດ੔എ̈́ΉͺίυΠ΋Ȝσͅ੔‫̱̀ݶ‬৘ঔ̳̠ͥ͢
୰ྶ̤̭̹ͬ̈́̽ȃ
ԇȅࠫȁ‫ض‬
ȁˑ႕͈ۛ৪̥ͣ൳փͬං̀দࡑͬ৘ঔ̱̹ȃ̷͈ඤ
ˍ႕͉Ȃႉ઄দࡑ͈ಎগ̹͂̈́̽ȃಎগၑဇ͉Ȃঘ
ཌ͈̹̜͛́ͥȃ̷͈ఈ͉Ȃခ‫ٺ‬মયͥ͢ͅদࡑ‫ܢ‬
଎ˍ ņőł ͈ࠬಎෛഽ་‫ا‬
‫ۼ‬ಎ͈ಎগ͉̥̹̈́̽ȃEPA ൎဓ߲ˎ႕Ȃ΋ϋΠυȜ
σ߲ˎ႕͈෸ࠊ̞̾̀ͅȪນˍȫͅમܱ̱̹ȃদࡑ
‫ٳ‬ইஜ͉ͅˎ͈߲̤̞̾̀ͅ᫭ម͈อ୆͉ࡉ̴ͣͦȂ
BMI ̥ͣ͜೩‫͈ူו‬చય͉͙̥̹ͣͦ̈́̽ȃ
ນˍ చય৪͈ခྫ
଎ˎ ńœő ฽؊͈ࠬಎෛഽ་‫ا‬
ਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭࢌ‫ڠ‬໐ȁਜ਼ഛ൴༗࠲ۭࢌࡄ‫ݪ‬ȁలˏ‫ے‬ȪijıIJĶȫ
19
ͥࠫ͢‫خ̜ͥ́ض‬ෝ଻ͬ੆͓̞̀ͥˏȫȃ
ȁ͉ࣽٝȂఉ‫ث‬ະ཈გডཛॸ͈‫ူו‬स͉̩́̈́Ȃ‫ږ‬
৘ͅൎဓ̦‫خ‬ෝ̈́࿪सͬঀဥ̷̱͈࠿બ̤̭ͬ̈́̽
̹ȃႉ઄দࡑ‫ٳ‬ইশ̤̞͉̀ͅȂEPA ൎဓ߲Ȃ΋ϋ
ΠυȜσ߲̤̞̀ͅ᫭មอ୆͉ࡉ̴ͣͦ BMI ̥ͣ͜
೩‫͈ူו‬చય͉ࡉ̥̹̦ͣͦ̈́̽Ȃව֭ IJIJ ඾࿒ͅ΋
ϋΠυȜσ߲͈ۛ৪̤̞̀ͅ᫭ម͈ࠁ଼̦͙̹ͣͦȃ
͘ ̹ȂEPA ൎ ဓ ߲ ͉ ς ϋ Ω ‫ ͈ ݩ‬ତ ౵ ̦ ࣞ ౵ͬা̱Ȃ
‫׶‬છͅచ̳ͥ྾‫ܥע‬ෝ̦̞ࣞ߹̦͙̹࢜ͣͦȃEPA
଎ˏ ςϋΩ‫͈ࠬݩ‬ಎෛഽ་‫ا‬
͉ͅ‫׶‬છ͈ဲଷ࢘ͅ‫̤̥̦̭̜̦ͤ̀̽ͩ͂ͥض‬ˑȫȂ
ࣽٝȂփেવ‫̜͈ۛͥٺ‬৪̜̹̦́̽Ȃࠐ‫ۯ‬ൎဓͅ
‫ܥ‬ෝ͈ঐດ͂̈́ͥςϋΩ‫ݩ‬Ȫ଎ˏȫ͈ව֭ IJĵ ඾࿒͈
ͤ͢‫ږ‬৘ͅ EPA ͬൎဓ̱̹̭͂́‫׶‬છ͈ဲଷ̦൱̧Ȃ
་‫ͬا‬๤‫͙̱͂ͥ̀ڛ‬ȂEijȪEPA ൎဓ߲ȫ͈ۛ৪͂
᫭មอ୆͈ဲଷ̦̹̭̦̾̈́̽͂ͅাऐ̯̹ͦȃ̭
CIJĭ ˎȪ΋ϋΠυȜσ߲ȫ̷̸͉ͦͦ‫׶‬છ฽؊̦ࣞ౵
͉ͦȂࠐ‫ٳူוۯ‬ইশͅક‫ܕا‬છે൝ͤ͢ͅ‫ږ‬৘̈́
ͬা̱̹ȃ̱̥̱ȂςϋΩ‫ ͉́ݩ‬EijȪEPA ൎဓ߲ȫ
‫ူו‬ၷ༹̦ࣾඳ̈́ۛ৪͉͂̽̀ͅȂ‫ږ‬৘ͅ EPA ͈ൎ
͈ۛ৪͉ CIJȪ΋ϋΠυȜσ߲ȫ͂๤‫̳ࣞ͂ͥڛ‬౵ͬ
ဓ̧̦́Ȃ᫭ម͈อ୆ͬဲଷ̧́ͥ࢘‫ܢ̦ض‬ఞ̧́
া̱̤̀ͤȂEPA ͬൎဓ̱̹༷̦྾‫ܥע‬ෝ̦̥ࣞ̽
̭̦ͥ͂ଔ௶̯̹ͦȃ
̹ȃ̤̈́ȂςϋΩ‫ ͈ݩ‬EIJȪEPA ൎဓ߲ȫ͈ IJĵ ඾࿒
ȁ̱̥̱Ȃུࡄ‫͉ݪ‬છ႕ତ̦ઁ̥̹̹̈́̽͛Ȃൡࠗ
͈ΟȜΗ͉࠿औະෝ̜̹̹́̽͛ȂΟȜΗͬං̭ͥ
എٜ̈́ଢ଼ͤ͢ͅ‫۾‬Ⴒ଻ͬྶ̧̥̳̭̦ͣͥ͂́̈́ͅ
̧͉̥̹͂́̈́̽ȃ
̥̹̽ȃ̹͘Ȃۭࢌ঍ͅచ̱̀᫭មΉͺ͉ດ੔എ̈́Ή
ͺίυΠ΋Ȝσͬ੔‫̠̳ͥ͢ݶ‬୰ྶ̤̭̞ͬ̈́৘ঔ
Ԉȅࣉȁख़
̱̹̦ͬȂࠐࡑාତ൝ͤ͢ͅΉͺτασ̦အș̜́̽
ȁ᫭ម̦୆̲̳̞ۛ͞৪͈ఉ̩͉Ȃ೒ુ૙ͬࠐ࢛̥
̹ȃࣽࢃ͉ΟȜΗͬୟ͙ਹ͇ͥ͂͂͜ͅȂ᫭មΉͺ
ͣ୫̱৾̀͜‫ူו‬ਫ਼ါၾͬྖ̧̹̳̭̦̞̹͂́̈́
ͅచ̳ۭͥࢌ঍͈͒‫̹͛܄ͬ֗ޗ‬ͺίυȜΙͬ࠿൦
͛Ȃࠐ࢛‫ူו‬༞੩૙຦̦ခဥ̜̭̦́ͥ͂༭̯࣬ͦ
̱ȂEPA ͈ൎဓ̦᫭ម͈อ୆ͬဲଷ̧̥́ͥྶ̥ͣ
̞̀ͥ˓ȫȃෞࠬ‫ۯ‬৖ۛۛ৪ཻ͉ត൝͈੄࡛ͤ͢ͅȂ୫
̱̞̩̀ͅȃ̹͘ȂEPA ͈ൎဓͥ͢ͅ᫭មอ୆͈ဲ
૙ታ‫ئ‬વ‫̭̦ͤܳٺ‬Ȃ࢘‫ض‬എ̈́‫ူו‬ၷ༹̦ࣾඳ̈́ΉȜ
ଷ̦֓ၷ΋ΑΠۭ͞ࢌΉͺ͈໅౜ͅ‫̥͈̳ͥޣג‬൝Ȃ
Α̦ఉ̞ȃ̯ͣͅȂ‫ݢݣ‬เ௣̯ͦව̱̹֭ۛ৪͉Ȃհ
ఉ༷࿂̥ͣ࠿બ̱̞̩̭̦̀͂ࣽࢃ͈‫ه‬ఴ̜́ͥȃ
୓ٓ઄ͬ‫̹̞͛ͥͦͣޑ‬Ȃ᫭មอ୆͈ςΑ·̦̞ࣞȃ
̷͈̹͛Ȃ᫭មထཡͬ࿒എ்̱̹͂‫ۯူו͈̥ͣܢ‬
ԉȅࠫȁა
ၑ͈͒ٚව̦ਹါ͂̈́ͥȃ
ȁ᫭មอ୆͈ΧͼςΑ·͂ࣉ̢ͣͦͥփেવ‫ͬٺ‬
ȁఉ‫ث‬ະ཈გডཛॸͥ͢ͅ᫭ម͈ထཡͅ‫͉̱̀۾‬Ȃ ৽ஶͅ‫ݢݣ‬เ௣̯ͦව̱̹֭ෞࢸणۛ৪ͅచ̱̀Ȃ
EPAȆGLA ‫اޑ‬ෛ࢚ၠ൲૙͈ൎဓͬෞ૰ࠐ‫੅਀شٸ‬
ņőł ͈ൎဓ̦᫭ម͈อ୆ͬဲଷ̳̥ͥͬ࠿൦̱̹ࠫ
છ႕ۛ৪࣐̞ͅȂ᫭មอ୆ထཡ࢘‫̹ͦͣ͛෇̦ض‬ȃ̷
‫ض‬Ȃո‫͈ئ‬ത̦‫̹̯ͦ෇ږ‬ȃ
͈ါ֦̱͂̀Ȃఉ‫ث‬ະ཈გডཛॸ͈‫׶‬છဲଷ࢘‫ͅض‬
ˍȫEPA ͬൎဓ̱̹߲͉́Ȃచચ߲ͅ๤͓̀᫭ម͈
20
ࣱ୼‫ج‬ঊȇෞࢸणۛ৪͈᫭មထཡ̤̫ͥͅఉ‫ث‬ະ཈გডཛॸ‫ူו‬ൎဓ͈࠿൦
อ୆̦෇̥̹͛ͣͦ̈́̽ȃ
ˑȫPalombo JD,DeMichele SJ,Boyce PJ,et al:Effect
ˎȫȁȁȁͬൎဓ̱̹߲͉́ȂςϋΩ‫̦ࣞݩ‬౵ͬা̱Ȃ
of short-term enteral feeding with eicosapentaenoEPA
྾‫ܥע‬ෝ̦̞ࣞ߹̜̭̦࢜ͥ͂ͅাऐ̯̹ͦȃ
ic and gamma-linolenic acids on alveolar macro-
̤̈́Ȃུࡄ‫͉ݪ‬໹଼ ijĶ ාഽ‫ڠ‬ಿඅ༆‫ވ‬൳ίυΐͿ·
phage eicosanoid synthesis and bactericidal func-
Πࡄ‫͈ݪ‬੩଼ͬ਋̫࣐̹̀̽ࡄ‫͈֚ݪ‬໐̜́ͥȃ
tion in rats. Crit Care Med 27(9),1908-1915,1999.
˒ȫAndreassi M,Forleo P,Di Lorio A,et al:Efficacy of
Ⱥ֨ဥ໲ࡃȻ
gamma-linolenic acid in the treatment of patients
ˍȫඤ‫ຸڝ‬ȇ໹଼ ijĶ ාๅࣞႢ২ٛฒ੥ȄijijĮijĶȄ൐‫ނ‬Ȅ with atopic dermatitis,J Int Mde Res 25(5),266ȁȁijıIJĴį
274,1997.
ˎȫ൥ࡔઆȄઐ‫ז‬ೄঊȄ߷൞֭౶‫ج‬Ȅఈȇࣞෛഽͺη
˓ȫEuropean Pressure Ulcer Advisory Panel and Na-
ȁȁΦॸ໅‫ͤ͢ͅك‬٨஝̦෇̹͛ͣͦ༌ଅ͈᫭មછ
tional Pressure Ulcer Advisory Panel:Prevention
ȁȁ႕Ȅ୓ྤࠐಸ‫ူו‬ȄijĺȪːȫȄIJıIJĮIJıķȄijıIJĵȅ
and treatment of pressure ulcers:quick reference
ˏȫ઀୼߰Ȅऎș࿐ঃ෕Ȅ߬ఆ੓ঊȄఈȇ΀ͼ΋΍
guide.National pressure ulcer Advisory panel,Wa-
ȁȁβϋΗ΀ϋॸȆ Ϲ ĮςΦτϋॸ‫اޑ‬ෛ࢚ၠ൲૙ൎ
shington DC,2009.
ȁȁဓͥ͢ͅ᫭ម͈ထཡ࢘‫ض‬Ƚෞ૰ࠐ‫੅਀شٸ‬છ႕
˔ȫఱ‫໌׆‬຃Ȅଫࡔ߼Ȅഛ࿤ຶআঊȄఈ Ļġ ۭࢌْࠗͬ
ȁȁ͈ਔ੅‫ۯူוܢ‬ၑ͈࠿൦ȽȄਜ਼ഛ൴ఱ‫ڠ‬༗࠲ۭ
ȁȁၛ̀ͥष͈᫭ម‫ࡏܓ‬ါ֦Ȫఱ‫׆‬ȆཱനΑΉȜσȫ
ȁȁࢌȁࡄ‫ܮݪ‬ါȄˍȪˍȫ
ȄˍĮIJıȄijıIJijį
ȁȁ͈ဥ̞༷͈৘ष͂ບ‫ث‬Ƚ೰५ࠌພ֭ȄΠπΗܱැ
ːȫZurier RB,Rossetti RG,Jacobson EW,et al:A gam-
ȁ
ȁȁພ͈֭৘ष͂ບ‫ث‬ȽȄExpert NurseȄijıȪĵȫȄ
ma-linolenic acid treatment of rheuma-toid arth-
ȁȁIJijĹĮIJĴĸĭijııĵį
ritis.A randomized,placebo-controlled trial.Arth-
˕ȫ඾ུ᫭ម‫ڠ‬ٛ༎ȇ᫭មచॐ͈ঐૻȄચႅ২Ȅijııijȅ
ritis Rheum 39(11),1808-1817.1996.